Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial.
EClinicalMedicine(2023)
摘要
Yunnan Province Science and Technology Department (grant no.202302AA310047).
更多查看译文
关键词
inactivated vaccines,immunogenicity,double-blinded
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要